Polycyclic aromatic hydrocarbons: Correlations between DNA adducts and ras oncogene mutations

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 424, Issue 1-2, 1999, Pages 155-166

  Ross, Jeffrey A ^a   Nesnow, Stephen ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

DNA adduct; Oncogene; Polycyclic aromatic hydrocarbon; Tumor

Indexed keywords

POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL EXPERIMENT; ANIMAL MODEL; DNA ADDUCT; GENE MUTATION; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RAT; REVIEW; TUMOR;

ANIMALIA;

EID: 0033535436     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00016-0     Document Type: Article

References (59)

1. IARC, Polynuclear aromatic compounds, Part 1. Chemical, environmental, and experimental data, IARC Monogr. Eval. Carcinog. Risks Hum. Suppl., 32, 1983.
2. R.G. Harvey, Polycyclic aromatic hydrocarbons, chemistry and carcinogenicity, Cambridge Univ. Press, Cambridge, UK, 1991.
3. IARC, Overall evaluations of carcinogenicity: an updating of the IARC monographs Vol. 1-42, IARC Monogr. Eval. Carcinog. Risks Hum. Suppl., 7, 1987.
4. Maronpot R.R., Fox T., Malarkey D.E., Goldsworthy T.L. Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology. 101:1995;125-156.
5. Nelson E. Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants. Crit. Rev. Toxicol. 26:1996;483-549.
6. Stanley L.A. Molecular aspects of chemical carcinogenesis: the roles of oncogenes and tumour suppressor genes. Toxicology. 96:1995;173-194.
7. Reynolds S.H., Anderson M.W. Activation of proto-oncogenes in human and mouse lung tumors. Environ. Health Perspect. 93:1991;145-148.
8. You M., Candrian U., Maronpot R.R., Stoner G.D., Anderson M.W. Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. U.S.A. 86:1989;3070-3074.
9. Leone-Kabler S., Wessner L.L., McEntee M.F., Agostino J.D., Miller M.S. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally-induced murine lung tumors. Carcinogenesis. 18:1997;1163-1168.
10. Falzon M., Vu V.T., Roller P.P., Thorgeirsson S.S. Relationship between 7,12-dimethyl- and 7,8,12-trimethylbenz[a]anthracene DNA adduct formation in hematopoietic organs and leukemogenic effects. Cancer Lett. 37:1987;41-49.
11. Osaka M., Matsuo S., Koh T., Sugiyama T. Loss of heterozygosity at the N-ras locus in 7,12-dimethylbenz[a] anthracene-induced rat leukemia. Mol. Carcinog. 18:1997;206-212.
12. Osaka M., Matsuo S., Koh T., Liang P., Kinoshita H., Maeda S., Sugiyama T. N-ras mutation in 7,12-dimethylbenz[a]anthracene (DMBA)-induced erythroleukemia in Long-Evans rats. Cancer Lett. 91:1995;25-31.
13. Prahalad A.K., Ross J.A., Nelson G.B., Roop B.C., King L.C., Nesnow S., Mass M.J. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis. 18:1997;1955-1963.
14. Ralston S.L., Lau H.H.S., Seidel A., Luch A., Platt K.L., Baird W.M. Identification of dibenzo[a,l]pyrene-DNA adducts formed in cells in culture and in mouse skin. Polycyclic Aromatic Compounds. 6:1994;119-206.
15. Cavalieri E., Rogan E. Role of radical cations in aromatic hydrocarbon carcinogenesis. Environ. Health Perspect. 64:1985;69-84.
16. Chakravarti D., Pelling J.C., Cavalieri E.L., Rogan E.G. Relating aromatic hydrocarbon-induced DNA adducts and c-H-ras mutations in mouse skin papillomas: the role of apurinic sites. Proc. Natl. Acad. Sci. U.S.A. 92:1995;10422-10426.
17. Kunkel T.A. Mutational specificity of depurination. Proc. Natl. Acad. Sci. U.S.A. 81:1984;1494-1498.
18. Reardon D.B., Bigger C.A., Dipple A. DNA polymerase action on bulky deoxyguanosine and deoxyadenosine adducts. Carcinogenesis. 11:1990;165-168.
19. Klinedinst D.K., Drinkwater N.R. Mutagenesis by apurinic sites in normal and ataxia telangiectasia human lymphoblastoid cells. Mol. Carcinog. 6:1992;32-42.
20. Denissenko M.F., Chen J.X., Tang M.S., Pfeifer G.P. Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc. Natl. Acad. Sci. U.S.A. 94:1997;3893-3898.
21. Dittrich K.A., Krugh T.R. Mapping of (+/-)-anti-benzo[a]pyrene diol epoxide adducts to human c-Ha-ras1 protooncogene. Chem. Res. Toxicol. 4:1991;277-281.
22. Denissenko M.F., Pao A., Tang M., Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 274:1996;430-432.
23. Chen J.X., Pao A., Zheng Y., Ye X., Kisleyou A.S., Morris R., Slaga T.J., Harvey R.G., Tang M.S. Sequence preference of 7,12-dimethylbenz[a]anthracene-syn-diol epoxide-DNA binding in the mouse H-ras gene detected by UvrABC nucleases. Biochemistry. 35:1996;9594-9602.
24. DiGiovanni J., Beltran L., Rupp A., Harvey R.G., Gill R.D. Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons and papillomas from uninitiated, promoter-treated skin in SENCAR mice. Mol. Carcinog. 8:1993;272-279.
25. 32P-postlabeling Carcinogenesis. 18:1997;523-529.
26. Mass M.J., Jeffers A.J., Ross J.A., Nelson G., Galati A.J., Stoner G.D., Nesnow S. Ki-ras oncogene mutations in tumors and DNA adducts formed by benz[j]aceanthrylene and benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinog. 8:1993;186-192.
27. Mass M.J., Abu-Shakra A., Roop B.C., Nelson G., Galati A.J., Stoner G.D., Nesnow S., Ross J.A. Benzo[b]fluoranthene: tumorigenicity in strain A/J mouse lungs, DNA adducts and mutations in the Ki-ras oncogene. Carcinogenesis. 17:1996;1701-1704.
28. Li E.E., Heflich R.H., Bucci T.J., Manjanatha M.G., Blaydes B.S., Delclos K.B. Relationships of DNA adduct formation, K-ras activating mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice. Carcinogenesis. 15:1994;1377-1385.
29. Xia Q., Yi P., Zhan D.J., Von Tungeln L.S., Hart R.W., Heflich R.H., Fu P.P. Liver tumors induced in B6C3F1 mice by 7-chlorobenz[a]anthracene and 7-bromobenz[a]anthracene contain K-ras protooncogene mutations. Cancer Lett. 123:1998;21-25.
30. Nesnow S., Ross J.A., Nelson G., Wilson K., Roop B.C., Jeffers A.J., Galati A.J., Stoner G.D., Sangaiah R., Gold A., Mass M.J. Cyclopenta[cd]pyrene-induced tumorigenicity, Ki-ras codon 12 mutations and DNA adducts in strain A/J mouse lung. Carcinogenesis. 15:1994;601-606.
31. Loktionov A., Hollstein M., Martel N., Galendo D., Cabral J.R., Tomatis L., Yamasaki H. Tissue-specific activating mutations of Ha- and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA. Mol. Carcinog. 3:1990;134-140.
32. Manam S., Storer R.D., Prahalada S., Leander K.R., Kraynak A.R., Ledwith B.J., van Zwieten M.J., Bradley M.O., Nichols W.W. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice. Cancer Res. 52:1992;3347-3352.
33. Qing W.G., Conti C.J., LaBate M., Johnston D., Slaga T.J., MacLeod M.C. Induction of mammary cancer and lymphoma by multiple, low oral doses of 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis. 18:1997;553-559.
34. Wang X., Witschi H. Mutations of the Ki-ras protooncogene in 3-methylcholanthrene and urethan-induced and butylated hydroxytoluene-promoted lung tumors of strain A/J and SWR mice. Cancer Lett. 91:1995;33-39.
35. Wessner L.L., Fan M., Schaeffer D.O., McEntee M.F., Miller M.S. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis. 17:1996;1519-1526.
36. Niwa O., Kamiya K., Furihata C., Nitta Y., Wang Z., Fan Y.J., Ninomiya Y., Kotomura N., Numoto M., Kominami R. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas. Cancer Res. 55:1995;5670-5676.
37. You L., Wang D., Galati A.J., Ross J.A., Mass M.J., Nelson G.B., Wilson K.H., Amin S., Stoner J.C., Nesnow S., Stoner G.D. Tumor multiplicity, DNA adducts and K-ras mutation pattern of 5-methylchrysene in strain A/J mouse lung. Carcinogenesis. 15:1994;2613-2618.
38. Ronai Z.A., Gradia S., el-Bayoumy K., Amin S., Hecht S.S. Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide. Carcinogenesis. 15:1994;2113-2116.
39. Gill R.D., Beltran L., Nettikumara A.N., Harvey R.G., Kootstra A., DiGiovanni J. Analysis of point mutations in murine c-Ha-ras of skin tumors initiated with dibenz[a,j]anthracene and derivatives. Mol. Carcinog. 6:1992;53-59.
40. Bailleul B., Brown K., Ramsden M., Akhurst R.J., Fee F., Balmain A. Chemical induction of oncogene mutations and growth factor activity in mouse skin carcinogenesis. Environ. Health Perspect. 81:1989;23-27.
41. Andrews D.F. III, Collins S.J., Reddy A.L. Absence of the c-Ha-ras codon 61 point mutation in murine solid tumors induced by subcutaneously applied 7,12-dimethylbenzanthracene. Cancer Lett. 54:1990;139-145.
42. Corominas M., Leon J., Kamino H., Cruz-Alvarez M., Novick S.C., Pellicer A. Oncogene involvement in tumor regression: H-ras activation in the rabbit keratoacanthoma model. Oncogene. 6:1991;645-651.
43. Cardiff R.D., Gumerlock P.H., Soong M.M., Dandekar S., Barry P.A., Young L.J., Meyers F.J. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Oncogene. 3:1988;205-213.
44. Kito K., Kihana T., Sugita A., Murao S., Akehi S., Sato M., Tachibana M., Kimura S., Ueda N. Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas. Mol. Carcinog. 17:1996;78-83.
45. Gimenez-Conti I.B., Bianchi A.B., Stockman S.L., Conti C.J., Slaga T.J. Activating mutation of the Ha-ras gene in chemically induced tumors of the hamster cheek pouch. Mol. Carcinog. 5:1992;259-263.
46. Hecht S.S., Ronai Z.A., Dolan L., Desai D., Amin S. Comparative mouse skin tumorigenicity and induction of Ha-ras mutations by bay region diol epoxides of 5-methylchrysene and 5,6-dimethylchrysene. Carcinogenesis. 19:1998;157-160.
47. Brown K., Buchmann A., Balmain A. Carcinogen-induced mutations in the mouse c-Ha-ras gene provide evidence of multiple pathways for tumor progression. Proc. Natl. Acad. Sci. U.S.A. 87:1990;538-542.
48. Ross J.A., Nelson G.B., Wilson K.H., Rabinowitz J.R., Galati A., Stoner G.D., Nesnow S., Mass M.J. Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res. 55:1995;1039-1044.
49. Agarwal R., Canella K.A., Yagi H., Jerina D.M., Dipple A. Benzo[c]phenanthrene-DNA adducts in mouse epidermis in relation to the tumorigenicities of four configurationally isomeric 3,4-dihydrodiol 1,2-epoxides. Chem. Res. Toxicol. 9:1996;586-592.
50. DiGiovanni J., Decina P.C., Prichett W.P., Fisher E.P., Aalfs K.K. Formation and disappearance of benzo[a]pyrene DNA-adducts in mouse epidermis. Carcinogenesis. 6:1985;741-747.
51. Rogan E.G., Devanesan P.D., RamaKrishna N.V., Higginbotham S., Padmavathi N.S., Chapman K., Cavalieri E.L., Jeong H., Jankowiak R., Small G.J. Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6:1993;356-363.
52. Baer-Dubowska W., Nair R.V., Cortez C., Harvey R.G., DiGiovanni J. Covalent DNA adducts formed in mouse epidermis from dibenz[a,j]anthracene: evidence for the formation of polar adducts. Chem. Res. Toxicol. 8:1995;292-301.
53. Lurie A.G., Rozenski D.L., Coghill J.E. DNA adduct formation by 7,12-dimethylbenz(a)anthracene in Syrian hamster cheek pouch epithelium in vivo. Cancer Res. 48:1988;2025-2028.
54. DiGiovanni J., Fisher E.P., Sawyer T.W. Kinetics of formation and disappearance of 7,12-dimethylbenz(a)anthracene: DNA adducts in mouse epidermis. Cancer Res. 46:1986;4400-4405.
55. Devanesan P.D., RamaKrishna N.V., Padmavathi N.S., Higginbotham S., Rogan E.G., Cavalieri E.L., Marsch G.A., Jankowiak R., Small G.J. Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem. Res. Toxicol. 6:1993;364-371.
56. 32P-postlabeled rat mammary DMBA-DNA adducts Carcinogenesis. 11:1990;1959-1963.
57. Misra B., Amin S., Hecht S.S. Metabolism and DNA binding of 5,6-dimethylchrysene in mouse skin. Chem. Res. Toxicol. 5:1992;242-247.
58. Cooper C.S., Vigny P., Kindts M., Grover P.L., Sims P. The reaction of a 3-methylcholanthrene diol epoxide with DNA in relation to the binding of 3-methylcholanthrene to the DNA of mammalian cells. Carcinogenesis. 1:1980;855-860.
59. Osborne M.R., Brookes P., Lee H.M., Harvey R.G. The reaction of a 3-methylcholanthrene diol epoxide with DNA in relation to the binding of 3-methylcholanthrene to the DNA of mammalian cells. Carcinogenesis. 7:1986;1345-1350.